Lack of interleukin‐6 in the tumor microenvironment augments type‐1 immunity and increases the efficacy of cancer immunotherapy

Yosuke Ohno, Hidemitsu Kitamura, Hideaki Yurino et al.|Cancer Science|2017

Cited by 85